PRE Prenetics Global Earnings per share trend in current year
Prenetics Global leads in Asian precision genomics and early cancer diagnostics. This annual earnings per share trend visualizes this status, while the 7.20 metric determines this level. Prenetics Global balances between Western and PRC legal frameworks regarding biodata. Meanwhile, the bet on preventive medicine ensures business resilience regardless of market cyclicality.
Financial and market metric breakdowns for prenetics.com (PRE)
- current quotes and average value forecast:
- market capitalization data:
- issuer book value statistics:
- debt and liquidity details:
- net income and valuation multiples indicators:
PRE - Company Net Income|Company Profit Forecast Prenetics Global|PRE - Price to Earnings Ratio|Future Price to Earnings Multiple Prenetics|PRE - PEG Multiple|Enterprise Value to EBITDA Multiple Prenetics Global|PRE - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Prenetics|PRE - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months prenetics.com|PRE - Earnings growth in current year|Net earnings per share growth forecast for next year Prenetics Global
Summary company analysis:Prenetics Global Ltd - PRE
Investors utilize earnings per share (EPS) dynamics as a key benchmark for the fundamental stability of the business. By analyzing the change in EPS compared to the previous year, one can assess the efficiency of Prenetics Global (PRE) production outsourcing and IT infrastructure, as this indicator reflects real net income growth stripped of the influence of the total volume of diagnostic systems produced.
Direct competitors
A - Expected net earnings per share growth this year|Earnings per share growth in current year Quest|Illumina Platform - Earnings per share trend in current year|Earnings per share growth in current year Exact Sciences (EXAS)|RVTY (revvity.com) - Earnings per share increase in current year|Earnings growth in current year BIO (Bio-Rad)|Anbio Biotechnology Ltd (NNNN) - Earnings per share growth rate in current year|SHC - Earnings per share growth in current year|QDEL (QuidelOrtho Inc.) - Earnings per share growth this year|OPK: Earnings growth in current year|Earnings per share growth rate in current year CareDx (CDNA)|Net earnings per share growth this year MRVI|FLGT (Fulgent Genetics Inc) - Net earnings per one share growth for the current year|Earnings growth in current year LAB|Expected net earnings per share growth this year Cytek Corp|Earnings growth in current year OSUR (OraSure Technologies)|XGN - Net earnings per share growth this year|MDXH - Earnings per share growth in current year|Expected net earnings per share growth this year Lucid Diagnostics, Inc. LUCD|IMDX (imdxinc.com) - Net earnings per share growth this year|Trinity Biotech - Earnings per share increase in current year|PRPH (ProPhase Labs, Inc.) - Earnings growth in current year|AIMD - Net earnings per share change in current year|Earnings per share growth in current year Co-Diagnostics (CODX)|Earnings per share growth in current year HSCS (Heart Test Laboratories, Inc.)|Earnings per share growth in current year Biomerica, Inc BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Earnings per share growth rate in current year|Onconetix, Inc. - Earnings growth in current year|VRAX: Earnings per share growth in current year|BJDX: Earnings growth in current year|Aspira Women's Health, Inc. (AWH) - Earnings growth in current year|Earnings per share growth in current year Accelerate Diagnostics, Inc|Earnings per share growth in current year CNTG|Earnings per share growth in current year Enzo Biochem, Inc. (ENZ)|FRES: Earnings per share trend in current year|Earnings per share growth in current year Genetic Technologies Limited GENE|Earnings per share increase in current year ME|Psychemedics Corp - Earnings growth in current year
